Neurology News

Approximately one in five parents responding to a national survey reported giving their child melatonin for sleep, researchers reported.

SAN DIEGO — A novel, oral therapeutic for treatment of migraine was safe and well-tolerated in single ascending doses in a cohort of healthy adults, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — The stigma that accompanies migraine is universal and often affects more than one personal or professional relationship, according to a speaker at the American Headache Society Annual Scientific Meeting.

As we enter the second half of 2024, it is important to understand some tax law changes that became effective this year and could affect your retirement savings and tax planning.

SAN DIEGO – Spontaneous intracranial hypotension led to significant physical, mental and quality of life impact for a cohort of those with the condition, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO —Individuals with episodic migraine had lower nutrient intake on days with nausea or vomiting compared with days without nausea, according to a poster from the American Headache Society Annual Scientific Meeting.

SAN DIEGO — A vaporized combination of THC and CBD was the most efficacious of four cannabis choices for acute moderate to severe migraine at 2 hours, according to an expert at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — AI-based models are currently best utilized as a predictor of headache, but show promise for expansion into the health care continuum, according to a speaker at the American Headache Society Annual Scientific Meeting.

The AMA House of Delegates adopted several new policies to promote public health at its annual meeting.

Individuals diagnosed with glaucoma may benefit from increased monitoring for dementia symptoms, particularly if they were diagnosed at age 80 years or older, according to a study in Ophthalmology.